Please use this identifier to cite or link to this item:
Title: Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective.
Austin Authors: Howden, Benjamin P ;Ward, P B;Johnson, Paul D R ;Charles, Patrick G P ;Grayson, M Lindsay 
Affiliation: Infectious Diseases Department, Austin Health, Melbourne, Australia
Issue Date: 1-Feb-2005
Publication information: European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology; 24(2): 100-8
Abstract: Low-level vancomycin resistance in Staphylococcus aureus has emerged as a clinical problem over the past 8 years. The clinical relevance of this resistance has been questioned, and laboratory detection remains difficult and time consuming. There is, however, increasing evidence linking low-level vancomycin resistance with glycopeptide treatment failure in serious Staphylococcus aureus infections. Diagnostic laboratories and clinicians need to be aware of this resistance phenotype, to have procedures in place to detect the resistance, and to have strategies for managing patients with infections caused by resistant strains.
Gov't Doc #: 15682283
DOI: 10.1007/s10096-004-1261-y
Type: Journal Article
Subjects: Aged
Aged, 80 and over
Anti-Bacterial Agents.pharmacology
Methicillin Resistance
Microbial Sensitivity Tests
Staphylococcal Infections.drug therapy.microbiology
Staphylococcus aureus.drug effects
Vancomycin Resistance
Appears in Collections:Journal articles

Files in This Item:
File SizeFormat 
15682283.pdf56.6 kBAdobe PDFView/Open
Show full item record

Page view(s)

checked on Dec 4, 2022


checked on Dec 4, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.